Date: Monday 23 Apr 2012
GW Pharmaceuticals, the developer of cannabis-based medicinal products, has released a puff piece about a favourable review of its Sativex product in a US medical journal.
| Ophir Energy director makes massive sale | 02-Apr-2012 | ShareCast |
| UPDATE: Tuesday broker round-up | 25-Oct-2011 | ShareCast |
| Tuesday tips round-up: Elementis, Genus, GW Phar... | 05-Jul-2011 | ShareCast |
| GW now expects small full year profit | 17-May-2011 | ShareCast |
| GW Pharma signs Sativex deal with Novartis | 11-Apr-2011 | ShareCast |
| Director/PDMR Shareholding | 23-May-2012 | 15:56 | RNS |
| Third Cancer Pain Trial Commences | 22-May-2012 | 07:00 | RNS |
| Interim Results | 22-May-2012 | 07:00 | RNS |
| Successful completion of MRP for Sativex | 08-May-2012 | 07:00 | RNS |
| Notice of Results | 26-Apr-2012 | 11:00 | RNS |
| Novartis drug deal is just the tonic for GW Phar... | 12-Apr-2011 | Daily Mail |
| GW SIGNS £20M SATIVEX DEAL WITH NOVARTIS | 12-Apr-2011 | Express & Star |
| GW signs Sativex cannabis-based drug deal with N... | 12-Apr-2011 | Telegraph |
| GW up 51% on Sativex trial data | 12-Mar-2009 | The Independent |
| Narrowed losses at GW Pharmaceuticals | 20-Jun-2008 | The Independent |
| Investment Column:GW Pharmaceuticals | 21-May-2009 | The Independent |
| Market report: Monday latest | 08-Sep-2008 | Daily Mail |
| Market report: Tuesday latest | 08-Apr-2008 | Daily Mail |
| Questor: GW Pharmaceuticals | 23-Jan-2008 | Telegraph |
| The Investment Column: GW Pharmaceuticals | 23-Jan-2008 | The Independent |
No recent information was found.
| GW strikes deal over cannabis-based pain drug | 12-Apr-2011 | This Is Money |
| Cannabis spray boosts GW profits | 24-Nov-2010 | This Is Money |
| FTSE in-depth: Petropavlovsk loses its sparkle | 04-Nov-2010 | This Is Money |
| Newspaper and magazine share tips | 10-Sep-2010 | This Is Money |
| Midas Extra share tips: Costain, GW Pharmaceut... | 16-Nov-2009 | This Is Money |
| Currency | UK Pounds |
| Share Price | 80.25p |
| Change Today | 1.00p |
| % Change | 1.26 % |
| 52 Week High | 130.00 |
| 52 Week Low | 78.50 |
| Volume | 70,999 |
| Shares Issued | 133.32m |
| Market Cap | £106.99m |
| Beta | 0.34 |
| RiskGrade | 538 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| No dividends found |
| Time | Volume / Share Price |
| 15:42 | 4,725 @ 79.50p |
| 15:41 | 4,725 @ 79.50p |
| 15:13 | 5,450 @ 79.50p |
| 15:13 | 4,000 @ 79.50p |
| 15:12 | 1,000 @ 79.58p |
You are here: research